To include your compound in the COVID-19 Resource Center, submit it here.
Merck will acquire ophthalmic company Inspire for $5 per share, or about $430 million in cash. The price is a 26% premium to Inspire's
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury